87 related articles for article (PubMed ID: 4371322)
1. Demonstration of the in vivo action of pepstatin: effects on plasma angiotensin II concentration.
Lazar J; Oster P; Gross F; Hackenthal E
Biochem Pharmacol; 1974 Oct; 23(19):2776-8. PubMed ID: 4371322
[No Abstract] [Full Text] [Related]
2. Proceedings: Demonstration of the in vivo action of pepstatin: effects on plasma angiotensin II concentration (PAC).
Oster P; Lazar J; Hackenthal E
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R73. PubMed ID: 4367358
[No Abstract] [Full Text] [Related]
3. Proceedings: Some similarities and differences between renin and sustained pressor principle.
De Vito E; Koninckx A; Miller RP
Acta Physiol Lat Am; 1973; 23(6):519-20. PubMed ID: 4369062
[No Abstract] [Full Text] [Related]
4. Cause of the prolonged pressor action of renin in nephrectomized rats. Elucidated by means of anti-angiotensin II and of angiotensin-inhibitor (1-sar-8-ala-angiotensin II).
Bing J; Nielsen K
Acta Pathol Microbiol Scand A; 1973 May; 81(3):247-53. PubMed ID: 4358385
[No Abstract] [Full Text] [Related]
5. Pepstatin: lack of inhibition of the human renin-angiotensinogen reaction.
García RL; Croxatto HR; Roblero JS
Acta Physiol Lat Am; 1974; 24(1):92-3. PubMed ID: 4372859
[No Abstract] [Full Text] [Related]
6. On the pressor effect of angiotensin and renin before and after nephrectomy in dogs.
Freire-Maia L
Acta Physiol Lat Am; 1969; 19(3):202-9. PubMed ID: 4313920
[No Abstract] [Full Text] [Related]
7. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
Allan DR; Hui KY; Coletti C; Hollenberg NK
J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383
[TBL] [Abstract][Full Text] [Related]
8. Role of renin as a blood-borne hormone tested by infusion of renin inhibitor (H.77).
Tree M; Fraser R; Holloway C; Hughes M; Ingram M; Leckie BJ; Lever AF; Morton JJ; Szelke M
Kidney Int Suppl; 1988 Sep; 25():S33-7. PubMed ID: 3054239
[No Abstract] [Full Text] [Related]
9. Synthesis and renin inhibitory properties of a new soluble pepstatin derivative.
Gardes J; Evin G; Castro B; Corvol P; Menard J
J Cardiovasc Pharmacol; 1980; 2(5):687-98. PubMed ID: 6157960
[TBL] [Abstract][Full Text] [Related]
10. Renin inhibition by pepstatin in experimental hypertension.
Schölkens BA; Jung W
Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):24-34. PubMed ID: 4844368
[No Abstract] [Full Text] [Related]
11. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP
J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
[TBL] [Abstract][Full Text] [Related]
12. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
13. Non-specific inhibition of pressor agents in vivo by the renin inhibitor pepstatin A.
Oldham AA; Arnstein MJ; Major JS; Clough DP
J Hypertens; 1984 Apr; 2(2):157-61. PubMed ID: 6398334
[TBL] [Abstract][Full Text] [Related]
14. In vivo effects of anti-angiotensin II on the renin-system. Share of the reninsystem in the normal blood pressure level, and the mechanism of the changed response to renin in nephrectomised rats.
Bing J; Poulsen K
Acta Pathol Microbiol Scand; 1968; 74(1):139-40. PubMed ID: 4302582
[No Abstract] [Full Text] [Related]
15. Reinvestigation of the cause of the increased velocity of reaction between renin and angiotensinogen in plasma from nephrectomised rats.
Bing J
Acta Pathol Microbiol Scand; 1969; 75(1):33-6. PubMed ID: 4307673
[No Abstract] [Full Text] [Related]
16. Effects of the renin inhibitor N-[N-(3-(4-amino-1-piperidinyl-carbonyl)-2(R)-benzylpropionyl)-L- histid inyl] -(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6(2-pyridyl)-hexane-2-amide acetate in anesthetized rhesus monkeys.
Linz W; Heitsch H; Henning R; Jung W; Kleemann HW; Nickel WU; Ruppert D; Urbach H; Wagner A; Schölkens BA
Arzneimittelforschung; 1994 Jul; 44(7):815-20. PubMed ID: 7945514
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Azizi M; Guyene TT; Chatellier G; Ménard J
J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
[TBL] [Abstract][Full Text] [Related]
18. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
Rasmussen S; Ibsen H; Giese J
Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
[TBL] [Abstract][Full Text] [Related]
19. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of dog renin activity by pepstatin A.
Miyazaki M; Komori T; Okunishi H; Toda N
Jpn Circ J; 1979 Sep; 43(9):818-23. PubMed ID: 501901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
